A
Arbutus Biopharma (ABUS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Arbutus Biopharma (ABUS)
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more
- USD4.54
- USD4.61
- USD4.45
- USD5.10
- 7.10%
- 16M
- 135.08k
- 1.29M
- 845M
- 2.71
- 9.60%
Stock News
1 hour ago
We're initiating a position in a company that is a key player in the AI buildout
CNBC
1 hour ago
Coca-Cola’s stock rises as revenue beats forecasts and profit increases
MarketWatch
3 hours ago
What Recent Analyst Adjustments Mean for Golden Entertainment’s Evolving Story and Valuation
Yahoo
6 hours ago
Yen Sold As Takaichi Becomes Japan's Prime Minister
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
